These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 8712735)
21. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Nishida N; Fukuda Y; Kokuryu H; Toguchida J; Yandell DW; Ikenega M; Imura H; Ishizaki K Cancer Res; 1993 Jan; 53(2):368-72. PubMed ID: 8093350 [TBL] [Abstract][Full Text] [Related]
22. Comparison of allelic losses in chondroblastoma and primary chondrosarcoma of bone and correlation with fluorescence in situ hybridization analysis. Papachristou DJ; Goodman MA; Cieply K; Hunt JL; Rao UN Hum Pathol; 2006 Jul; 37(7):890-8. PubMed ID: 16784990 [TBL] [Abstract][Full Text] [Related]
23. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas. Jin W; Xu X; Yang T; Hua Z Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043 [TBL] [Abstract][Full Text] [Related]
24. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection. Kim JW; Lee CG; Han SM; Kim KS; Kim JO; Lee JM; Kim IK; Namkoong SE Gynecol Oncol; 1997 Nov; 67(2):215-21. PubMed ID: 9367711 [TBL] [Abstract][Full Text] [Related]
25. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. Dodson MK; Hartmann LC; Cliby WA; DeLacey KA; Keeney GL; Ritland SR; Su JQ; Podratz KC; Jenkins RB Cancer Res; 1993 Oct; 53(19):4456-60. PubMed ID: 8402612 [TBL] [Abstract][Full Text] [Related]
26. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas. Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927 [TBL] [Abstract][Full Text] [Related]
27. Bladder cancer: allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and grade. Wada T; Louhelainen J; Hemminki K; Adolfsson J; Wijkström H; Norming U; Borgström E; Hansson J; Sandstedt B; Steineck G Clin Cancer Res; 2000 Feb; 6(2):610-5. PubMed ID: 10690546 [TBL] [Abstract][Full Text] [Related]
28. Mutation spectrum of the retinoblastoma gene in osteosarcomas. Wadayama B; Toguchida J; Shimizu T; Ishizaki K; Sasaki MS; Kotoura Y; Yamamuro T Cancer Res; 1994 Jun; 54(11):3042-8. PubMed ID: 8187094 [TBL] [Abstract][Full Text] [Related]
29. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Murakami Y; Hayashi K; Hirohashi S; Sekiya T Cancer Res; 1991 Oct; 51(20):5520-5. PubMed ID: 1655254 [TBL] [Abstract][Full Text] [Related]
30. Possible association of p53 overexpression and mutation with high-grade chondrosarcoma. Dobashi Y; Sugimura H; Sato A; Hirabayashi T; Kanda H; Kitagawa T; Kawaguchi N; Imamura T; Machinami R Diagn Mol Pathol; 1993 Dec; 2(4):257-63. PubMed ID: 8118603 [TBL] [Abstract][Full Text] [Related]
31. Allelotype analysis of esophageal squamous cell carcinoma. Shibagaki I; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K Cancer Res; 1994 Jun; 54(11):2996-3000. PubMed ID: 8187088 [TBL] [Abstract][Full Text] [Related]
32. [Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer]. Kashkin KN; Fleĭshman EV; Chumakov PM; Perevoshchikov AG Genetika; 1998 Aug; 34(8):1049-55. PubMed ID: 9777351 [TBL] [Abstract][Full Text] [Related]
33. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
34. p53 mutations and prognosis in bladder tumors. Uchida T; Wada C; Ishida H; Wang C; Egawa S; Yokoyama E; Kameya T; Koshiba K J Urol; 1995 Apr; 153(4):1097-104. PubMed ID: 7869472 [TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer. Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314 [TBL] [Abstract][Full Text] [Related]
36. An uncertain role for p53 gene alterations in human prostate cancers. Brooks JD; Bova GS; Ewing CM; Piantadosi S; Carter BS; Robinson JC; Epstein JI; Isaacs WB Cancer Res; 1996 Aug; 56(16):3814-22. PubMed ID: 8706029 [TBL] [Abstract][Full Text] [Related]
37. Analyses of p53 gene mutations in primary human bladder cancer. Miyamoto H; Kubota Y; Shuin T; Torigoe S; Hosaka M; Iwasaki Y; Danenberg K; Danenberg PV Oncol Res; 1993; 5(6-7):245-9. PubMed ID: 8123944 [TBL] [Abstract][Full Text] [Related]
38. Loss of somatic heterozygosity in hepatocellular carcinoma. Walker GJ; Hayward NK; Falvey S; Cooksley WG Cancer Res; 1991 Aug; 51(16):4367-70. PubMed ID: 1678314 [TBL] [Abstract][Full Text] [Related]
39. Role of chromosome 9 in human bladder cancer. Miyao N; Tsai YC; Lerner SP; Olumi AF; Spruck CH; Gonzalez-Zulueta M; Nichols PW; Skinner DG; Jones PA Cancer Res; 1993 Sep; 53(17):4066-70. PubMed ID: 8358736 [TBL] [Abstract][Full Text] [Related]
40. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms. Yamaguchi K; Sugano K; Fukayama N; Nakashima Y; Saotome K; Yokoyama T; Yokota T; Ohkura H Am J Gastroenterol; 1997 Feb; 92(2):307-12. PubMed ID: 9040212 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]